A case report of pregnancy in a patient with common variable immunodeficiency emphasizing the need for personalized immunoglobulin replacement

RATIONALE: Subcutaneous immunoglobulin administration facilitated by recombinant human hyaluronidase is a new mode of immunoglobulin replacement. It has been approved for treatment in primary and secondary antibody immunodeficiency. To date, it has not been reported in the literature as therapy of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Więsik-Szewczyk, Ewa, Jahnz-Różyk, Karina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221563/
https://www.ncbi.nlm.nih.gov/pubmed/30383634
http://dx.doi.org/10.1097/MD.0000000000012804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221563/
https://www.ncbi.nlm.nih.gov/pubmed/30383634
http://dx.doi.org/10.1097/MD.0000000000012804

Ejemplares similares